Functionalised gold nanoparticles for controlling pathogenic bacteria. 2010

Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
Department of Applied Chemistry, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.

The increasing number of bacterial strains that are resistant to available pharmaceutical compounds is a vital issue for public health. Innovative approaches will be required to improve the methods for both diagnosis and destruction of these organisms. Here, we consider the possible role that can be played by technologies based on gold nanoparticles. Gold nanoparticles generally are considered to be biologically inert but can be engineered to possess chemical or photothermal functionality. A growing body of research is devoted to the potential use of these nanoparticles in the diagnosis and treatment of bacterial infections. The results are both promising and intriguing, and suggest a range of new strategies to identify, target or destroy pathogenic organisms.

UI MeSH Term Description Entries
D006046 Gold A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle

Related Publications

Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
March 2015, Chemical communications (Cambridge, England),
Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
December 2007, Nanomedicine (London, England),
Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
August 2019, IET nanobiotechnology,
Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
January 2015, ACS applied materials & interfaces,
Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
December 2018, World journal of gastroenterology,
Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
February 2022, ACS applied bio materials,
Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
May 2021, Applied microbiology and biotechnology,
Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
January 2014, Faraday discussions,
Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
October 2015, Chemistry (Weinheim an der Bergstrasse, Germany),
Dakrong Pissuwan, and Colin H Cortie, and Stella M Valenzuela, and Michael B Cortie
June 2011, Small (Weinheim an der Bergstrasse, Germany),
Copied contents to your clipboard!